{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/09/3308857/0/en/Ernexa-Therapeutics-Highlights-Ovarian-Cancer-Unmet-Need-Hope-for-Patients-and-Potential-Accessibility-Advantages-of-ERNA-101-in-Virtual-Investor-KOL-Connect-Segment-Featuring-Dr-I.html", "message": "News view counter 788493 successfully enlarged"}